Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
|Articles|October 15, 2004
Ophthalmology test set for physicians-in-training
Fairfax, VA-Physicians-in-training in ophthalmology may take the Ophthalmic Knowledge Assessment Program examination April 16, 2005, in Washington, DC.
Advertisement
Fairfax, VA-Physicians-in-training in ophthalmology may take the Ophthalmic Knowledge Assessment Program examination April 16, 2005, in Washington, DC.
The exam, which will be administered by the American Academy of Ophthalmology (AAO), will be held from 8 a.m. to 1 p.m. at the Washington Convention Center during the American Society of Cataract and Refractive Surgery Annual Symposium in Washington, DC.
For more information about the exam, contact Stacey Samuels at the AAO in San Francisco at 415/447-0262.
Advertisement
Related to this article
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Ophthalmology is projected to face one of the steepest physician shortages of any subspecialty by 2038.
Two investigational pipeline therapies take aim at the root causes of dry eye disease
Dry eye care pivots to root-cause diagnosis and personalized biologics/devices,
Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.
June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Comments from the FDA Advisory Committee meeting on SYD-101
2
OCT-980 receives FDA orphan drug designation for retinitis pigmentosa
3
First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP
4
FAQ: Diabetic eye disease awareness month 2026
5